Mark Bertolini Buys 1,000,000 Shares of Oscar Health (NYSE:OSCR) Stock

Oscar Health, Inc. (NYSE:OSCR) CEO Mark Bertolini purchased 1,000,000 shares of the stock in a transaction that occurred on Monday, April 6th. The shares were acquired at an average cost of $11.92 per share, for a total transaction of $11,920,000.00. Following the completion of the transaction, the chief executive officer owned 10,196,876 shares of the company’s stock, valued at $121,546,761.92. This trade represents a 10.87% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Oscar Health Stock Performance

NYSE:OSCR traded up $0.20 during mid-day trading on Tuesday, reaching $12.96. 6,753,082 shares of the company’s stock were exchanged, compared to its average volume of 7,963,210. Oscar Health, Inc. has a one year low of $10.69 and a one year high of $23.80. The firm has a market capitalization of $3.86 billion, a PE ratio of -7.45 and a beta of 1.93. The business’s fifty day simple moving average is $13.16 and its two-hundred day simple moving average is $15.78. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.96 and a current ratio of 0.96.

Oscar Health (NYSE:OSCR) last released its quarterly earnings results on Tuesday, February 10th. The company reported ($1.24) EPS for the quarter, missing analysts’ consensus estimates of ($0.92) by ($0.32). Oscar Health had a negative return on equity of 39.35% and a negative net margin of 3.79%.The business had revenue of $2.81 billion for the quarter, compared to the consensus estimate of $3.12 billion. During the same period in the prior year, the business posted ($0.62) earnings per share. Oscar Health’s revenue was up 17.3% compared to the same quarter last year. Analysts anticipate that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Institutional Trading of Oscar Health

Hedge funds have recently added to or reduced their stakes in the stock. Farther Finance Advisors LLC boosted its position in Oscar Health by 4,420.7% in the third quarter. Farther Finance Advisors LLC now owns 1,311 shares of the company’s stock valued at $25,000 after buying an additional 1,282 shares in the last quarter. Jones Financial Companies Lllp boosted its position in Oscar Health by 7,473.3% in the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock valued at $30,000 after buying an additional 2,242 shares in the last quarter. Strs Ohio acquired a new stake in Oscar Health in the first quarter valued at approximately $30,000. Fifth Third Bancorp boosted its position in Oscar Health by 148.7% in the fourth quarter. Fifth Third Bancorp now owns 2,363 shares of the company’s stock valued at $34,000 after buying an additional 1,413 shares in the last quarter. Finally, Quarry LP boosted its position in Oscar Health by 439.8% in the third quarter. Quarry LP now owns 1,803 shares of the company’s stock valued at $34,000 after buying an additional 1,469 shares in the last quarter. Institutional investors and hedge funds own 75.70% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have commented on OSCR shares. Wall Street Zen raised shares of Oscar Health from a “sell” rating to a “hold” rating in a report on Saturday, February 14th. Weiss Ratings reissued a “sell (d)” rating on shares of Oscar Health in a report on Thursday, January 22nd. Stephens started coverage on shares of Oscar Health in a report on Thursday, December 11th. They issued an “equal weight” rating and a $17.00 target price on the stock. Raymond James Financial raised shares of Oscar Health from a “market perform” rating to an “outperform” rating and set a $18.00 target price on the stock in a report on Thursday, February 12th. Finally, Barclays set a $18.00 target price on shares of Oscar Health and gave the company an “equal weight” rating in a report on Monday, January 5th. Two equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $16.88.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.